The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

Show other versions (1)

Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using liver fibrosis as an example.

Bibliographic Details
Main Authors:	Gangadharan, B, Kumar, A, Barnes, E, Klenerman, P, Dwek, R, Zitzmann, N
Format:	Conference item
Published:	Wiley 2016

Similar Items

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
by: Gangadharan, B, et al.
Published: (2016)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
by: Gangadharan, B, et al.
Published: (2015)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
by: Gangadharan, B, et al.
Published: (2014)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
by: Gangadharan, B, et al.
Published: (2012)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2016)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2014)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2007)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
by: Gangadharan, B, et al.
Published: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
by: Gangadharan, B, et al.
Published: (2012)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
by: Gangadharan, B, et al.
Published: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
by: Gangadharan, B, et al.
Published: (2008)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
by: Gangadharan, B, et al.
Published: (2010)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
by: Kumar, A, et al.
Published: (2014)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
by: Bevin Gangadharan, et al.
Published: (2012-01-01)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
by: Pardo, M, et al.
Published: (2007)

Towards the first antibody-free serum biomarker assay for NAFLD
by: Gangadharan, B, et al.
Published: (2017)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
by: Gangadharan, B
Published: (2017)

Towards the first antibody-free serum biomarker assay for NAFLD
by: Gangadharan, B, et al.
Published: (2017)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
by: Narayan, R, et al.
Published: (2009)

Applying proteomics technology to platelet research.
by: García, A, et al.
Published: (2005)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
by: Woodhouse, S, et al.
Published: (2010)

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
by: Yi Luo, et al.
Published: (2021-05-01)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
by: Gangadharan, B, et al.
Published: (2011)

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
by: Bharucha, T, et al.
Published: (2019)

Differential proteome analysis of CRP-activated platelets
by: Garcia, A, et al.
Published: (2005)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
by: Kumar, A, et al.
Published: (2017)

Diagnostics of Fibrosis in Alcoholic Liver Damage
by: E. N. Travenko, et al.
Published: (2019-09-01)

Non-invasive Diagnostics of Liver Fibrosis
by: Mihaylov R., et al.
Published: (2017-05-01)

Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.
by: Antrobus, R, et al.
Published: (2009)

Use of iminosugar derivatives to inhibit ion channel activity
by: Zitzmann, N, et al.
Published: (2004)

Serum biomarkers for liver fibrosis assessment
by: Maroto-García Julia, et al.
Published: (2023-11-01)

Proteome analysis of human uveal melanoma cells by two-dimensional gel electrophoresis and mass spectrometry
by: Pardo, M, et al.
Published: (2005)

Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
by: Pardo, M, et al.
Published: (2005)

Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children
by: Yasser E Nassef, et al.
Published: (2013-11-01)

Salivary biomarkers and proteomics: future diagnostic and clinical utilities
by: M. Castagnola, et al.
Published: (2017-04-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry
by: García, A, et al.
Published: (2004)

Multiple reaction monitoring and multiple reaction monitoring cubed based assay for the quantitation of apolipoprotein F
by: Kumar, A, et al.
Published: (2016)